We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Benign Hematology

Journal Scan / Research · April 17, 2021

Detection of Circulating Plasma Cells May Improve Risk Stratification of Patients With Newly Diagnosed Multiple Myeloma

British Journal of Haematology

 

Additional Info

British Journal of Haematology
The Detection of Circulating Plasma Cells May Improve the Revised International Staging System (R-ISS) Risk Stratification of Patients With Newly Diagnosed Multiple Myeloma
Br. J. Haematol 2021 Apr 01;[EPub Ahead of Print], P Galieni, F Travaglini, D Vagnoni, M Ruggieri, P Caraffa, C Bigazzi, S Falcioni, P Picardi, S Mazzotta, E Troiani, A Dalsass, F Mestichelli, M Angelini, E Camaioni, D Maravalle, S Angelini, V Pezzoni

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading